Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Pharmacoeconomics
|
December 8, 1997
Single European currency and Monetary Union. Macroeconomic implications for pharmaceutical spending
P Kanavos
Pharmacoeconomics
|
January 7, 1998
A prospective view on European pharmaceutical research and development. Policy options to reduce fragmentation and increase competitiveness
P Kanavos
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2006
The rising burden of cancer in the developing world
P Kanavos
Croatian Medical Journal
|
May 11, 1999
Financing pharmaceuticals in transition economies
P Kanavos
Pharmacoeconomics
|
March 3, 2001
The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings
P Kanavos
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement: an Empirical Case Study
A Angelis, P Kanavos
Health Economics
|
May 3, 2000
Health economics: an evolving paradigm
A Maynard, P Kanavos
Pharmacoeconomics
|
October 28, 1999
Outstanding regulatory aspects in the European pharmaceutical market
P Kanavos, E Mossialos
Health Policy (Amsterdam, Netherlands)
|
August 5, 1997
Health policy versus industrial policy in the pharmaceutical sector: the case of Canada
M Vandergrift, P Kanavos
Journal of Health Services Research & Policy
|
February 24, 2001
Cross-border issues in the provision of health services: are we moving towards a European health care policy?
P Kanavos, M McKee
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Pharmacoeconomics
|
December 8, 1997
Single European currency and Monetary Union. Macroeconomic implications for pharmaceutical spending
P Kanavos
Pharmacoeconomics
|
January 7, 1998
A prospective view on European pharmaceutical research and development. Policy options to reduce fragmentation and increase competitiveness
P Kanavos
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2006
The rising burden of cancer in the developing world
P Kanavos
Croatian Medical Journal
|
May 11, 1999
Financing pharmaceuticals in transition economies
P Kanavos
Pharmacoeconomics
|
March 3, 2001
The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings
P Kanavos
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement: an Empirical Case Study
A Angelis, P Kanavos
Health Economics
|
May 3, 2000
Health economics: an evolving paradigm
A Maynard, P Kanavos
Pharmacoeconomics
|
October 28, 1999
Outstanding regulatory aspects in the European pharmaceutical market
P Kanavos, E Mossialos
Health Policy (Amsterdam, Netherlands)
|
August 5, 1997
Health policy versus industrial policy in the pharmaceutical sector: the case of Canada
M Vandergrift, P Kanavos
Journal of Health Services Research & Policy
|
February 24, 2001
Cross-border issues in the provision of health services: are we moving towards a European health care policy?
P Kanavos, M McKee
Page
of 3